Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis

被引:70
作者
Arness, T. [2 ]
Pedersen, R. [3 ]
Dierkhising, R. [3 ]
Kremers, W. [3 ]
Patel, R. [1 ,4 ]
机构
[1] Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA
关键词
varicella; herpes zoster; shingles; kidney transplant;
D O I
10.1111/j.1399-3062.2007.00289.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Varicella zoster virus (VZV)-related disease, particularly herpes zoster, is a complication of organ transplantation due to long-term immunosuppression. We determined the incidence and risk factors for post-transplant VZV infection by retrospectively reviewing the medical records of a cohort of 612 adult renal transplant recipients transplanted at Mayo Clinic Rochester between October 1, 2001 and October 1, 2004. Thirty-seven subjects developed herpes zoster, corresponding to a follow-up time-adjusted incidence of 11.2% at 4 years post transplant. The incidence rate of zoster was relatively constant between 6 months and 4 years, yielding an average incidence of approximately 28 per 1000 person-years. The risk of developing post-transplant zoster increased with increasing age at transplant, with each decade conferring a 1.42-fold (P = 0.009) increase in risk of zoster development. Seronegativity at time of transplant conferred over 3 times the risk of development of post-transplant zoster (hazard ratio 3.4; P = 0.04) compared with seropositivity. Adult kidney transplant recipients are at high risk for the development of post-transplant zoster.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 22 条
  • [1] Aging, immunity, and the varicella-zoster virus
    Arvin, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) : 2266 - 2267
  • [2] Health status ten years after pediatric liver transplantation - Looking beyond the graft
    Avitzur, Y
    De Luca, E
    Cantos, M
    Jimenez-Rivera, C
    Jones, N
    Fecteau, A
    Grant, D
    Ng, VL
    [J]. TRANSPLANTATION, 2004, 78 (04) : 566 - 573
  • [3] BROYER M, 1985, POSTGRAD MED J, V61, P103
  • [4] The incidence of shingles and its implications for vaccination policy
    Chapman, RS
    Cross, KW
    Fleming, DM
    [J]. VACCINE, 2003, 21 (19-20) : 2541 - 2547
  • [5] Response to varicella immunization in pediatric liver transplant recipients
    Donati, M
    Zuckerman, M
    Dhawan, A
    Hadzic, N
    Heaton, N
    North-Lewis, P
    Mieli-Vergani, G
    [J]. TRANSPLANTATION, 2000, 70 (09) : 1401 - 1404
  • [6] Successful vaccination against varicella zoster virus prior to kidney transplantation
    Geel, A
    Zuidema, W
    van Gelder, T
    van Doornum, G
    Weimar, W
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 952 - 953
  • [7] GIACCHINO R, 1995, TRANSPLANTATION, V60, P1055
  • [8] Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era
    Gourishankar, S
    McDermid, JC
    Jhangri, GS
    Preiksaitis, JK
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) : 108 - 115
  • [9] Herpes zoster after liver transplantation: Incidence, risk factors, and complications
    Herrero, JI
    Quiroga, J
    Sangro, B
    Pardo, F
    Rotellar, F
    Alvarez-Cienfuegos, J
    Prieto, J
    [J]. LIVER TRANSPLANTATION, 2004, 10 (09) : 1140 - 1143
  • [10] Skin infections in renal transplant recipients
    Hogewoning, AA
    Goettsch, W
    van Loveren, H
    de Fijter, JW
    Vermeer, BJ
    Bavinck, JNB
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (01) : 32 - 38